• Je něco špatně v tomto záznamu ?

Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition

MP. Quinn, V. Kratky, M. Whitehead, SS. Gill, MA. McIsaac, RJ. Campbell

. 2023 ; 37 (11) : 2233-2239. [pub] 20221206

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016788
E-zdroje Online Plný text

NLK Free Medical Journals od 2011
PubMed Central od 2011 do Před 1 rokem
Europe PubMed Central od 2011 do Před 1 rokem
ProQuest Central od 2002-01-01 do Před 1 rokem
Open Access Digital Library od 2002-01-01
Health & Medicine (ProQuest) od 2002-01-01 do Před 1 rokem

Odkazy

PubMed 36473973
DOI 10.1038/s41433-022-02322-w
Knihovny.cz E-zdroje

BACKGROUND/OBJECTIVES: Adverse effects of topical glaucoma medications (TGMs) may include development of ocular adnexal disorders. We undertook a study to determine the effect of TGMs on the risk of developing lacrimal drainage obstruction (LDO) and eyelid malposition. SUBJECTS/METHODS: All patients 66 years of age and older in Ontario, Canada initiating TGM and all patients diagnosed with glaucoma/suspected glaucoma but not receiving TGM from 2002 to 2018 were eligible for inclusion in this retrospective cohort study. Using validated healthcare administrative databases, cohorts were identified with TGM and no TGM patients matched 1:2 on sex and birth year. The effect of TGM treatment on risk of surgery for LDO and lid malpositions was estimated using Kaplan-Meier and Cox proportional hazards models. RESULTS: Cohorts included 122,582 patients in the TGM cohort and 232,336 patients in the no TGM cohort. Among the TGM cohort there was decreased event-free survival for entropion (log-rank P < 0.001), trichiasis (P < 0.001), and LDO (P = 0.006), and increased ectropion-free survival (P = 0.007). No difference in ptosis-free survival was detected (P = 0.78). For the TGM cohort there were increased hazards for entropion (hazard ratio [HR] 1.24, 95% confidence interval [CI] 1.12-1.37; P < 0.001), trichiasis (HR 1.74, 95% CI 1.57-1.94; P < 0.001), and LDO (at 15 years: HR 2.39, 95% CI 1.49-3.85; P = 0.004), and a decreased hazard for ectropion (HR 0.89, 95% CI 0.81-0.97; P = 0.008). No association between TGM treatment and ptosis hazard was detected (HR 0.99, 95% CI 0.89-1.09; P = 0.78). CONCLUSIONS: TGMs are associated with an increased risk of undergoing surgery for LDO, entropion, and trichiasis.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016788
003      
CZ-PrNML
005      
20231026105538.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41433-022-02322-w $2 doi
035    __
$a (PubMed)36473973
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Quinn, Matthew P $u Department of Ophthalmology, Queen's University, Kingston, ON, Canada. m.quinn@queensu.ca $u Department of Ophthalmology, Kingston Health Sciences Centre, Kingston, ON, Canada. m.quinn@queensu.ca $1 https://orcid.org/0000000319879265
245    10
$a Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition / $c MP. Quinn, V. Kratky, M. Whitehead, SS. Gill, MA. McIsaac, RJ. Campbell
520    9_
$a BACKGROUND/OBJECTIVES: Adverse effects of topical glaucoma medications (TGMs) may include development of ocular adnexal disorders. We undertook a study to determine the effect of TGMs on the risk of developing lacrimal drainage obstruction (LDO) and eyelid malposition. SUBJECTS/METHODS: All patients 66 years of age and older in Ontario, Canada initiating TGM and all patients diagnosed with glaucoma/suspected glaucoma but not receiving TGM from 2002 to 2018 were eligible for inclusion in this retrospective cohort study. Using validated healthcare administrative databases, cohorts were identified with TGM and no TGM patients matched 1:2 on sex and birth year. The effect of TGM treatment on risk of surgery for LDO and lid malpositions was estimated using Kaplan-Meier and Cox proportional hazards models. RESULTS: Cohorts included 122,582 patients in the TGM cohort and 232,336 patients in the no TGM cohort. Among the TGM cohort there was decreased event-free survival for entropion (log-rank P < 0.001), trichiasis (P < 0.001), and LDO (P = 0.006), and increased ectropion-free survival (P = 0.007). No difference in ptosis-free survival was detected (P = 0.78). For the TGM cohort there were increased hazards for entropion (hazard ratio [HR] 1.24, 95% confidence interval [CI] 1.12-1.37; P < 0.001), trichiasis (HR 1.74, 95% CI 1.57-1.94; P < 0.001), and LDO (at 15 years: HR 2.39, 95% CI 1.49-3.85; P = 0.004), and a decreased hazard for ectropion (HR 0.89, 95% CI 0.81-0.97; P = 0.008). No association between TGM treatment and ptosis hazard was detected (HR 0.99, 95% CI 0.89-1.09; P = 0.78). CONCLUSIONS: TGMs are associated with an increased risk of undergoing surgery for LDO, entropion, and trichiasis.
650    _2
$a lidé $7 D006801
650    12
$a entropion $x diagnóza $x etiologie $x chirurgie $7 D004774
650    _2
$a retrospektivní studie $7 D012189
650    12
$a trichiáza $x komplikace $7 D058457
650    12
$a ektropion $x etiologie $x chirurgie $7 D004483
650    12
$a glaukom $x komplikace $7 D005901
650    12
$a blefaroptóza $7 D001763
650    _2
$a oční víčka $7 D005143
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kratky, Vladimir $u Department of Ophthalmology, Queen's University, Kingston, ON, Canada $u Department of Ophthalmology, Kingston Health Sciences Centre, Kingston, ON, Canada $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Whitehead, Marlo $u ICES, Toronto, ON, Canada
700    1_
$a Gill, Sudeep S $u ICES, Toronto, ON, Canada $u Division of Geriatric Medicine, Queen's University, Kingston, ON, Canada $u Division of Geriatric Medicine, Kingston Health Sciences Centre, Kingston, ON, Canada
700    1_
$a McIsaac, Michael A $u School of Mathematical and Computational Sciences, University of Prince Edward Island, Charlottetown, PE, Canada
700    1_
$a Campbell, Robert J $u Department of Ophthalmology, Queen's University, Kingston, ON, Canada $u Department of Ophthalmology, Kingston Health Sciences Centre, Kingston, ON, Canada $u ICES, Toronto, ON, Canada
773    0_
$w MED00001754 $t Eye (London, England) $x 1476-5454 $g Roč. 37, č. 11 (2023), s. 2233-2239
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36473973 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105532 $b ABA008
999    __
$a ok $b bmc $g 2000370 $s 1203150
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 37 $c 11 $d 2233-2239 $e 20221206 $i 1476-5454 $m Eye $n Eye $x MED00001754
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace